RPG Life Sciences FY26 Annual Report and AGM Notice filed

Board & Shareholder Meetings View source PDF

RPGLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.1%1-day move

₹2342.20

prior close

₹2366.70

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2+0.1+0.3+2.3+3.1+4.6+5.1+4.4+13.8+20.0+23.9———

Up moveDown movePending

AI summary

RPG Life Sciences filed its FY2025-26 Annual Report along with the 19th AGM notice (July 23, 2026 via video conferencing) and the Business Responsibility and Sustainability Report. Revenue grew 8.3 percent to Rs 707.5 crores with an EBITDA margin of 24.4 percent. PAT stood at Rs 51.5 crores. Domestic Formulations led growth at 13.8 percent to Rs 483.5 crores, while International Formulations declined 6.7 percent. The Board recommended a dividend of Rs 24 per share (300 percent).

Likely market impact

Routine compliance filing. Strong domestic growth and a healthy Rs 24 per share dividend (300 percent) are positive signals for shareholders.